Cargando…
Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia
We present the largest to date of a case series of nine patients with hematological and oncological malignancies who were infected with Middle East Respiratory Syndrome Coronavirus (MERS-CoV). MERS-CoV is a novel beta-coronavirus with a high fatality rate in comorbid patients. The majority of MERS c...
Autores principales: | Alaskar, Ahmed, Bosaeed, Mohammed, Rehan, Hina, Mendoza, May Anne, Alahmari, Bader, Othman, Adel, Alhejazi, Ayman, Abuelgasim, Khadega, Damlaj, Moussab, Alzahrani, Mohsen, Gmati, Giamal, Salama, Hind, Abolfotouh, Mostafah, Shaheen, Naila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223241/ http://dx.doi.org/10.1182/blood-2019-123253 |
Ejemplares similares
-
Outcome of Middle East Respiratory Syndrome (MERS) in hematology and oncology patients: A case series in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2021) -
Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review
por: Abuelgasim, Khadega A., et al.
Publicado: (2020) -
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
por: Abuelgasim, Khadega A., et al.
Publicado: (2019) -
Reducing Central Venous Catheter Use in Peripheral Blood Stem Cell Donation: Quality Improvement Report
por: Ghazi, Samer, et al.
Publicado: (2017) -
Promising remissions in relapsed refractory classical Hodgkin lymphoma patients requiring multiple salvage regimens before transplantation in the brentuximab vedotin era
por: Abuelgasim, Khadega A, et al.
Publicado: (2021)